Regulatory Science in Practice (Pharmaceuticals and Medical Devices Agency)

被引:1
|
作者
Hojo, Taisuke [1 ]
机构
[1] Pharmaceut & Med Devices Agcy, Chiyoda Ku, 3-3-2 Kasumigaseki, Tokyo 1000013, Japan
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 2017年 / 137卷 / 04期
关键词
Pharmaceuticals and Medical Devices Agency; regulatory science; drug evaluation; Science Committee;
D O I
10.1248/yakushi.16-00244-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Review, safety, and relief services of the Pharmaceuticals and Medical Devices Agency are primarily focused on scientifically evaluating pharmaceuticals, medical devices, and cellular and tissue-based products referring to their quality, efficacy, and safety, which requires a variety of scientific knowledge and methods. Pharmaceutical regulation should be established based on the most advanced scientific expertise at all times. In order to evaluate products that use cutting edge technology such as induced pluripotent stem cells and information and communication technology adequately, since fiscal year 2012 the Science Committee has been established as a platform to exchange opinions among members from top-ranking domestic and international academia and to enhance personnel exchanges through the Initiative to Facilitate Development of Innovative Drugs. In addition, the Regulatory Science Center will be established in 2018 to increase the integrity of our services for product reviews and safety measures. In particular, requiring electronic data submissions for clinical trial applications followed by an advanced approach to analysis should not only enhance the quality of reviews of individual products but should also support the development of pharmaceuticals and medical devices by providing pharmaceutical affairs consultations on research and development strategies with various guidelines based on new insights resulting from product-bridging data analysis. Moreover, a database including electronic health records with comprehensive medical information collected mainly from 10 cooperating medical institutions will be developed with the aim of developing safety measures in a more timely manner using methods of pharmacoepidemiological analysis.
引用
收藏
页码:439 / 442
页数:4
相关论文
共 50 条
  • [1] The Roles of Regulatory Science Research in Drug Development at the Pharmaceuticals and Medical Devices Agency of Japan
    Asahina, Yasuko
    Tanaka, Ayumi
    Uyama, Yoshiaki
    Kuramochi, Kenji
    Maruyama, Hiroshi
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2013, 47 (01) : 19 - 22
  • [2] The Roles of Regulatory Science Research in Drug Development at the Pharmaceuticals and Medical Devices Agency of Japan
    Yasuko Asahina
    Ayumi Tanaka
    Yoshiaki Uyama
    Kenji Kuramochi
    Hiroshi Maruyama
    Therapeutic Innovation & Regulatory Science, 2013, 47 : 19 - 22
  • [3] Practice of Regulatory Science (Development of Medical Devices)
    Niimi, Shingo
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2017, 137 (04): : 431 - 437
  • [4] Japan Pharmaceuticals and Medical Devices Agency
    Nagai, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S38 - S38
  • [5] Future Vision of Regulatory Science in the Global Development of Pharmaceuticals and Medical Devices
    Nakamura, Mitsuhiro
    Ikeda, Koji
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2016, 136 (04): : 523 - 525
  • [6] Efforts of the Pharmaceuticals and Medical Devices Agency of Japanese regulatory agency in supporting biosimilar development and disseminate information
    Kuribayashi, Ryosuke
    Hariu, Aya
    Saino, Yuka
    Shinohara, Kayo
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [7] Advanced activities of the pharmaceuticals and medical devices agency (PMDA)
    Nagano, Tetsuo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S13 - S13
  • [8] MEDICAL DEVICES AND PHARMACEUTICALS: DIFFERENCES AND REGULATORY APPROACH
    Calis, Sema
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (01) : 12 - 13
  • [9] Guidelines for clinical evaluation of chronic kidney diseaseAMED research on regulatory science of pharmaceuticals and medical devices
    Eiichiro Kanda
    Naoki Kashihara
    Kunihiro Matsushita
    Tomoko Usui
    Hirokazu Okada
    Kunitoshi Iseki
    Kenichi Mikami
    Tetsuhiro Tanaka
    Takashi Wada
    Hirotaka Watada
    Kohjiro Ueki
    Masaomi Nangaku
    Clinical and Experimental Nephrology, 2018, 22 : 1446 - 1475
  • [10] What is regulatory science for medical devices?
    Yamane, Takashi
    JAPANESE JOURNAL OF ARTIFICIAL ORGANS, 2019, 48 (01): : 52 - 55